ArticleAnnals of pediatric cardiology
Technique, safety, efficacy, and optimal drug volume for erector spinae plane block in neonatal and infant cardiac surgery: A single-center experience with 295 cases.
Article in Annals of pediatric cardiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The erector spinae plane block (ESPB) is an emerging regional anesthesia technique gaining popularity for perioperative pain management in pediatric cardiac surgery. However, limited data exist on the feasibility, safety, hemodynamic stability, and efficacy of ESPB in neonates and infants undergoing cardiac procedures. This study aimed to evaluate the procedural safety, optimal drug volume, and its impact on ventilation duration, intensive care unit (ICU) length of stay (LOS), and opioid consumption in neonates and infants undergoing complex heart surgeries. Methods: Conducted at a tertiary pediatric cardiac center in Southern India from January 2021 to June 2023, this study included 295 infants (≤1 year) who received ESPB. These patients were compared with an equal number of neonates and infants who underwent cardiac surgery before ESPB implementation. Data were retrospectively reviewed from the International Quality Improvement Collaborative for Congenital Heart Disease and hospital records. Results: No procedure-related complications or intraoperative hemodynamic instability were observed in the ESPB group. The modified technique was easily administered, requiring 1 ml/kg for each hemithorax to achieve effective analgesia. The ESPB group showed significantly lower cumulative opioid consumption (400 [100-400] µg) compared to the pre-ESPB group (600 [250-600] µg). In addition, the duration of invasive mechanical ventilation was shorter (20 [11-43] h vs. 23 [16-43] h), and ICU LOS was reduced (72 [48-120] h vs. 96 [72-168] h). Conclusions: ESPB is a safe, feasible, and effective option for perioperative analgesia in neonates and infants undergoing cardiac surgery. Administering a volume of 1 ml/kg on each thorax provides optimal analgesia, reducing opioid use, invasive ventilation duration, and ICU LOS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.